跳至主要内容
临床试验/NCT06322641
NCT06322641已完成不适用

FLAME-ASCVD-Nephro A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD

研究概览

简要总结

The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • •Male or female, age above or equal to 18 years at the time of signing informed consent.
  • •Is a Nephrologist.
  • •Has been in practice greater than or equal to 3 years.
  • •Sees at least 20 patients with ASCVD and CKD per month.
  • •Treats patients for more than only dialysis

排除标准

  • •Previous participation in this study. Participation is defined as having given informed consent in this study
  • •Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • •Does not meet inclusion criteria requirements

结局指标

主要结局

Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD

时间窗: At the time of survey response (Day 1)

Multi-select from a defined list; Numerical; A 7-point Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree".

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验